FDA Import Refusal 231-5807543-6/1/2 — Aurobindo Pharma Limited
The FDA refused shipment 231-5807543-6/1/2 from Aurobindo Pharma Limited (India) on January 18, 2013. The refused product falls under Drugs and Biologics — METFORMIN HCL (ANTI-DIABETIC). Cited charge: 186 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- January 18, 2013
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA55 METFORMIN HCL (ANTI-DIABETIC)
- Charges
- 186